Dr. Reddy’s Laboratories Ltd (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. announces the launch of DailyBloom™ IBS, a pioneering digital integrated care plan for managing Irritable Bowel Syndrome (IBS) in India. The programme, unveiled on World IBS Day, offers a comprehensive care approach through a mobile application featuring diet management, psychological support, and personalized wellness plans. DailyBloom™ IBS is designed to enhance the standard of care for IBS patients, backed by extensive research and developed with inputs from multidisciplinary experts.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
